U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Norlys TV customers will see their monthly bills rise by up to 20 DKK starting July 1st. According to the company, this ...

Detailed price information for Texas Instruments (TXN-Q) from The Globe and Mail including charting and trades.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Easter in Denmark will be mostly without sun, but, with a bit of luck, also without heavy rain—at least most of the time. The ...

In the meantime, have a read of Emma Hanrahan’s piece on the Kingspan chief receiving backing from investor advisory firm ...

Lilly is also sending out about 50 cease-and-desist letters to compounders and telehealth ... Lilly competitor Novo Nordisk (NVO) has also experienced shortages of its GLP-1, semaglutide, marketed ...

Supply constraints have meant that the drug appears on the FDA's shortage list, which opens the door for compounding pharmacies to offer versions of the drug to patients. Last year, Novo Nordisk ...

Novo Nordisk (NYSE:NVO) stock has experienced a significant decline, dropping 35% from over $90 in early March to around $58 ...

In the latest trading session, Novo Nordisk (NVO) closed at $58.33, marking a +0.43% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 2.36% for the day.